NCBS - ニコレット・バンクシェア―ズ (Nicolet Bankshares Inc.)

NCBSのニュース

   Nicolet Bankshares, Inc. Announces First Quarter 2020 Earnings  2020/04/21 20:05:00 PR Newswire
GREEN BAY, Wis., April 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced first quarter 2020 net income of $10.6 million and earnings per diluted common share of $0.98, compared to $12.3 million and $1.18 for fourth quarter 2019, and $10.3 million and…
   Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon  2020/02/03 22:25:00 Zero Hedge
Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Via GreatGameIndia.com, In an explosive interview Dr. Francis Boyle, who drafted the Biological Weapons Act has given a detailed statement admitting that the 2019 Wuhan Coronavirus is an offensive Biological Warfare Weapon and that the World Health Organization (WHO) already knows about it. Dr. Francis Boyle Creator Of BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush. In an exclusive interview given to Geopolitics and Empire , Dr. Boyle discusses the coronavirus outbreak in Wuhan, China and the Biosafety Level 4 laboratory (BSL-4) from which he believes the infectious disease escaped.
   Bankshares, Inc. Announces Record 2019 Earnings  2020/01/21 21:05:00 PR Newswire
GREEN BAY, Wis., Jan. 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced fourth quarter 2019 net income of $12.3 million and earnings per diluted common share of $1.18, compared to $13.5 million and $1.40 for third quarter 2019, and $10.9 million and $1….
   Nicolet Bankshares (NCBS) Hits 52-Week High, Can the Run Continue?  2019/07/18 13:15:10 Zacks Investment Research
Nicolet Bankshares (NCBS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
   Nicolet Bankshares (NCBS) Beats Q2 Earnings and Revenue Estimates  2019/07/16 21:45:04 Zacks Investment Research
Nicolet Bankshares (NCBS) delivered earnings and revenue surprises of 21.43% and 25.34%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Nicolet Bankshares, Inc. Announces First Quarter 2020 Earnings  2020/04/21 20:05:00 PR Newswire
GREEN BAY, Wis., April 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced first quarter 2020 net income of $10.6 million and earnings per diluted common share of $0.98, compared to $12.3 million and $1.18 for fourth quarter 2019, and $10.3 million and…
   Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon  2020/02/03 22:25:00 Zero Hedge
Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Via GreatGameIndia.com, In an explosive interview Dr. Francis Boyle, who drafted the Biological Weapons Act has given a detailed statement admitting that the 2019 Wuhan Coronavirus is an offensive Biological Warfare Weapon and that the World Health Organization (WHO) already knows about it. Dr. Francis Boyle Creator Of BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush. In an exclusive interview given to Geopolitics and Empire , Dr. Boyle discusses the coronavirus outbreak in Wuhan, China and the Biosafety Level 4 laboratory (BSL-4) from which he believes the infectious disease escaped.
   Bankshares, Inc. Announces Record 2019 Earnings  2020/01/21 21:05:00 PR Newswire
GREEN BAY, Wis., Jan. 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced fourth quarter 2019 net income of $12.3 million and earnings per diluted common share of $1.18, compared to $13.5 million and $1.40 for third quarter 2019, and $10.9 million and $1….
   Nicolet Bankshares (NCBS) Hits 52-Week High, Can the Run Continue?  2019/07/18 13:15:10 Zacks Investment Research
Nicolet Bankshares (NCBS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
   Nicolet Bankshares (NCBS) Beats Q2 Earnings and Revenue Estimates  2019/07/16 21:45:04 Zacks Investment Research
Nicolet Bankshares (NCBS) delivered earnings and revenue surprises of 21.43% and 25.34%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon  2020/02/03 22:25:00 Zero Hedge
Creator Of US BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Via GreatGameIndia.com, In an explosive interview Dr. Francis Boyle, who drafted the Biological Weapons Act has given a detailed statement admitting that the 2019 Wuhan Coronavirus is an offensive Biological Warfare Weapon and that the World Health Organization (WHO) already knows about it. Dr. Francis Boyle Creator Of BioWeapons Act Says Coronavirus Is Biological Warfare Weapon Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush. In an exclusive interview given to Geopolitics and Empire , Dr. Boyle discusses the coronavirus outbreak in Wuhan, China and the Biosafety Level 4 laboratory (BSL-4) from which he believes the infectious disease escaped.
   Bankshares, Inc. Announces Record 2019 Earnings  2020/01/21 21:05:00 PR Newswire
GREEN BAY, Wis., Jan. 21, 2020 /PRNewswire/ -- Nicolet Bankshares, Inc. (NASDAQ: NCBS) ("Nicolet") announced fourth quarter 2019 net income of $12.3 million and earnings per diluted common share of $1.18, compared to $13.5 million and $1.40 for third quarter 2019, and $10.9 million and $1….
   Nicolet Bankshares (NCBS) Hits 52-Week High, Can the Run Continue?  2019/07/18 13:15:10 Zacks Investment Research
Nicolet Bankshares (NCBS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
   Nicolet Bankshares (NCBS) Beats Q2 Earnings and Revenue Estimates  2019/07/16 21:45:04 Zacks Investment Research
Nicolet Bankshares (NCBS) delivered earnings and revenue surprises of 21.43% and 25.34%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Nicolet Bankshares (NCBS) Earnings Expected to Grow: What to Know Ahead of Q2 Release  2019/07/09 14:30:28 Zacks Investment Research
Nicolet Bankshares (NCBS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

calendar